, Yoon Kyung Jeon1,3,4
, Doo Hyun Chung1,5,6
, Jaemoon Koh1,3
1Department of Pathology, Seoul National University College of Medicine, Seoul, Korea
2Department of Pathology, Seoul Metropolitan Government-Seoul National University Boramae Medical Center, Seoul, Korea
3Department of Pathology, Seoul National University Hospital, Seoul, Korea
4Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea
5Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Korea
6Ischemic/Hypoxic Disease Institute, Seoul National University College of Medicine, Seoul, Korea
© The Korean Society of Pathologists/The Korean Society for Cytopathology
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
PubReader
ePub Link
Cite this Article
| Variable | Value |
|---|---|
| Age (yr) | 47.7 (6–76) |
| Pediatrics | 14 (17.9) |
| Adult | 64 (82.1) |
| Sex | |
| Male | 59 (75.6) |
| Female | 19 (24.4) |
| Diagnosis | |
| CHF | 7 (9.0) |
| Dilated CMP | 43 (55.1) |
| Hypertrophic CMP | 1 (1.3) |
| Ischemic CMP | 16 (20.5) |
| Restrictive CMP | 2 (2.5) |
| Valvulopathy | 2 (2.5) |
| Amyloidosis | 4 (5.2) |
| Myocarditis | 1 (1.3) |
| Endocarditis | 1 (1.3) |
| Heart anomaly | 1 (1.3) |
| Smoking | |
| Never | 53 (67.9) |
| Ever | 25 (32.1) |
| Diabetes mellitus | |
| Absent | 55 (70.5) |
| Present | 23 (29.5) |
| Ventilator | |
| Not applied | 76 (97.5) |
| Applied | 2 (2.5) |
| BMI (kg/m2) | 20.9 (11.3–37.8) |
| Pre-operative EF (%) | 25.3 (12–77) |
| Post-operative EF (%) | 63.9 (49–77) |
| Ischemic time (min) | 182.9 (59–283) |
| Pulmonary artery pressure (mmHg) | 47.1 (25–84) |
| High-grade acute cellular rejection |
|||
|---|---|---|---|
| Absent (n = 62) | Present (n = 16) | p-value | |
| Age (yr) | |||
| <60 | 38 (77.6) | 11 (22.4) | .773 |
| ≥60 | 24 (82.8) | 5 (17.2) | |
| Sex | |||
| Male | 48 (81.4) | 11 (18.6) | .520 |
| Female | 14 (73.7) | 5 (26.3) | |
| CAD | |||
| Absent | 50 (79.4) | 13 (20.6) | >.99 |
| Present | 12 (80.0) | 3 (20.0) | |
| Diabetes | |||
| Absent | 45 (81.8) | 10 (18.2) | .540 |
| Present | 17 (73.9) | 6 (26.1) | |
| Hypertension | |||
| Absent | 45 (76.3) | 14 (23.7) | .330 |
| Present | 17 (89.5) | 2 (10.5) | |
| Smoking | |||
| Never | 43 (81.1) | 10 (18.9) | .873 |
| Ever | 19 (76.0) | 6 (24.0) | |
| Ventilator | |||
| Not applied | 60 (78.9) | 16 (21.1) | .334 |
| Applied | 2 (100) | 0 | |
| Dialysis | |||
| Never | 52 (77.6) | 15 (22.4) | .273 |
| Ever | 10 (90.9) | 1 (9.1) | |
| Body mass index (kg/m2) | 21.0 ± 4.1 | 20.7 ± 4.2 | .828 |
| Preoperative EF (%) | 25.5 ± 12.6 | 24.5 ± 10.3 | .764 |
| Postoperative EF (%) | 64.1 ± 6.4 | 62.9 ± 7.5 | .548 |
| Ischemic time (min) | 184.2 ± 58.7 | 177.6 ± 48.6 | .719 |
| Pulmonary artery pressure (mmHg) | 46.4 ± 14.4 | 50.6 ± 12.8 | .379 |
| Post-transplant survival (mo) | 32.6 ± 20.0 | 34.0 ± 19.4 | .806 |
| PD-L1 expression | |||
| Negative | 52 (89.7) | 6 (10.3) | <.001 |
| Positive | 10 (50.0) | 10 (50.0) | |
| PD-1+ lymphocytes (number/HPF) | 11.3 ± 20.5 | 31.3 ± 46.7 | .148 |
| CD8+ lymphocytes (number/HPF) | 89.8 ± 78.3 | 129.8 ± 102.3 | .175 |
| CD4+ lymphocytes (number/HPF) | 82.7 ± 72.4 | 170.5 ± 154.9 | .054 |
| PD-L1 expression | |||
|---|---|---|---|
| Absent (n = 58) | Present (n = 20) | p-value | |
| Age (yr) | |||
| <60 | 35 (71.4) | 14 (28.6) | .593 |
| ≥60 | 23 (79.3) | 6 (20.7) | |
| Sex | |||
| Male | 47 (79.7) | 12 (20.3) | .074 |
| Female | 11 (57.9) | 8 (42.1) | |
| CAD | |||
| Absent | 49 (77.8) | 14 (22.2) | .192 |
| Present | 9 (60.0) | 6 (40.0) | |
| Diabetes | |||
| Absent | 43 (78.2) | 12 (21.8) | .263 |
| Present | 15 (65.2) | 8 (34.8) | |
| Hypertension | |||
| Absent | 42 (71.2) | 17 (28.8) | .369 |
| Present | 16 (84.2) | 3 (15.8) | |
| Smoking | |||
| Never | 41 (77.4) | 12 (22.6) | .488 |
| Ever | 17 (68.0) | 8 (32.0) | |
| Ventilator | |||
| Not applied | 56 (73.7) | 20 (26.3) | .273 |
| Applied | 2 (100) | 0 | |
| Dialysis | |||
| Never | 50 (74.6) | 17 (25.4) | .894 |
| Ever | 8 (72.7) | 3 (27.3) | |
| Body mass index (kg/m2) | 21.1 ± 4.0 | 20.1 ± 4.9 | .480 |
| Preoperative EF (%) | 25.9 ± 12.5 | 21.4 ± 8.8 | .282 |
| Postoperative EF (%) | 63.7 ± 6.8 | 65.3 ± 4.9 | .521 |
| Ischemic time (min) | 183.9 ± 55.8 | 176.9 ± 63.7 | .733 |
| Pulmonary artery pressure (mmHg) | 46.0 ± 13.7 | 57.2 ± 14.5 | .066 |
| Post-transplant survival (mo) | 31.5 ± 19.2 | 42.4 ± 22.1 | .104 |
| PD-1+ lymphocytes (number/HPF) | 14.8 ± 24.7 | 35.6 ± 58.7 | .390 |
| CD8+ lymphocytes (number/HPF) | 91.6 ± 76.4 | 158.0 ± 119.2 | .059 |
| CD4+ lymphocytes (number/HPF) | 95.3 ± 105.2 | 198.4 ± 135.4 | .025 |
| Patient No. | Prior rejection | Rejection | Post-rejection |
|---|---|---|---|
| 1 | |||
| ACR grade | 0R | 2R | 0R |
| PD-L1 H-score | 0 | 14 | 0 |
| 2 | |||
| ACR grade | 1R | 2R | 1R |
| PD-L1 H-score | 0 | 0 | 0 |
| 3 | |||
| ACR grade | 0R | 2R | 0R |
| PD-L1 H-score | 0 | 0 | 0 |
| 4 | |||
| ACR grade | 0R | 2R | 0R |
| PD-L1 H-score | 0 | 5 | 0 |
| 5 | |||
| ACR grade | 0R | 2R | 0R |
| PD-L1 H-score | 0 | 5 | 0 |
| 6 | |||
| ACR grade | 0R | 3R | 0R |
| PD-L1 H-score | 5 | 50 | 0 |
| 7 | |||
| ACR grade | 0R | 2R | 0R |
| PD-L1 H-score | 2 | 0 | 0 |
| 8 | |||
| ACR grade | 0R | 2R | 0R |
| PD-L1 H-score | 0 | 6 | 0 |
| 9 | |||
| ACR grade | 1R | 2R | 1R |
| PD-L1 H-score | 5 | 2 | 0 |
| 10 | |||
| ACR grade | 1R | 2R | 1R |
| PD-L1 H-score | 0 | 0 | 0 |
| 11 | |||
| ACR grade | 2R | 3R | 0R |
| PD-L1 H-score | 3 | 15 | 0 |
| 12 | |||
| ACR grade | 0R | 2R | 2R |
| PD-L1 H-score | 0 | 0 | 0 |
| 13 | |||
| ACR grade | 1R | 3R | 2R |
| PD-L1 H-score | 0 | 0 | 0 |
Values are presented as mean (range) or number (%). CHF, chronic heart failure; CMP, cardiomyopathy; BMI, body mass index; EF, ejection fraction.
Values are presented as number (%) or mean ± SD. PD-1, programmed cell death-1; PD-L1, programmed death-ligand 1; CAD, coronary artery disease; EF, ejection fraction; HPF, high power field; SD, standard deviation. Cases with International Society for Heart and Lung Transplantation (ISHLT) grade 2R and 3R were considered to have high-grade acute cellular rejection.
Values are presented as number (%) or mean ± SD. PD-L1, programmed death-ligand 1; CAD, coronary artery disease; EF, ejection fraction; HPF, high power field; SD, standard deviation.
PD-L1, programmed death-ligand 1; ACR, acute cellular rejection; H-score, histochemical score.